SCM
HIMS icon

Soleus Capital Management’s Hims & Hers Health HIMS Stock Holding History

Soleus Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-333,000
Closed -$6.72M – 94
2024
Q2 		$6.72M Buy
+333,000
New +$5.54M 0.59% 53
2021
Q1 		– Sell
-281,565
Closed -$4.11M – 78
2020
Q4 		$4.11M Buy
+281,565
New +$3.13M 0.54% 23

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Soleus Capital Management's HIMS Position: Q3 2024 in Review

Soleus Capital Management sold out of Hims & Hers Health (HIMS) in Q3 2024, closing a stake of 333,000 shares — an estimated $6.72M sold.

Soleus Capital Management first reported a position in HIMS in Q4 2020 and held it in 2 quarters. The position peaked at $6.72M in Q2 2024. 308 funds tracked by Wall St. Rank hold HIMS as of Q3 2024.

  • Soleus Capital Management reported no remaining Hims & Hers Health position as of Q3 2024 after selling out during the quarter.
  • Soleus Capital Management sold 333,000 Hims & Hers Health shares in Q3 2024, an estimated $6.72M.
  • Soleus Capital Management first reported a position in Hims & Hers Health in Q4 2020 and held it in 2 quarters.
  • Soleus Capital Management's Hims & Hers Health position peaked at $6.72M in Q2 2024.
  • 308 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2024.

Based on Soleus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.